Ascendis Pharma ADR (ASND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 2,494 | 3,609 | 6,149 | 12,417 | 23 |
| Gross Profit | 2,494 | 3,609 | 6,149 | 12,417 | 23 |
| Operating Expenses | 62,559 | 61,580 | 70,073 | 53,238 | 44,540 |
| Operating Income | -60,065 | -57,970 | -63,924 | -40,821 | -44,516 |
| Interest Expense | 409 | 9,547 | 220 | -8,523 | 49 |
| Other Income | 32,480 | 1,236 | 3,144 | -3,931 | 4,955 |
| Pre-tax Income | -27,994 | -66,281 | -61,000 | -36,229 | -39,610 |
| Income Tax | -68 | -73 | -80 | -100 | -116 |
| Net Income Continuous | -27,926 | -66,208 | -60,921 | -36,129 | -39,493 |
| Net Income | $-27,926 | $-66,208 | $-60,921 | $-36,129 | $-39,493 |
| EPS Basic Total Ops | -0.59 | -1.41 | -1.41 | -0.83 | -0.94 |
| EPS Basic Continuous Ops | -0.59 | -1.40 | -1.40 | -0.83 | -0.94 |
| EPS Diluted Total Ops | -0.59 | -1.41 | -1.41 | -0.83 | -0.94 |
| EPS Diluted Continuous Ops | -0.59 | -1.40 | -1.40 | -0.83 | -0.94 |
| EBITDA(a) | $-57,968 | $-56,295 | $-62,452 | $-40,515 | $-44,256 |